Aizant Drug Research Solutions is a finished-dose manufacturer based in India. It appears in 47 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with INVIMA (CO), ARCSA (EC) and US FDA. Its GMP standing is certified by EMA, EAEU_EEC and MFDS (Korea), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 14 November 2025 as VAI. Customs aggregates show $12.7M of exports covering 233 molecules to 28 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hyderabad, India | 3025169808 |
| Hyderabad, India | 3008243902 |
| TELANGANA, India | Not on file |
| Medchal- Malkhajgiri District-500100, India | Not on file |
| Hyderabad, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| INVIMA (CO) | 16 | None |
| ARCSA (EC) | 11 | None |
| US FDA | 10 | 1 |
| MINSA (CR) | 6 | None |
| NPRA (MY) | 2 | None |
| DIGEMAPS (DO) | 1 | None |
| EMA | None | 4 |
| EAEU_EEC | None | 3 |
| MFDS (Korea) | None | 2 |
| ANVISA (Brazil) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.9M | 11 |
| 2025 | Not reported | $12.7M | 28 |
| 2024 | Not reported | $10.3M | 21 |
| 2023 | Not reported | $10.4M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Aizant Drug Research Solutions comes back tiered against every other supplier able to file there.
Start for free